× Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our privacy policy



meta|IO

Living evidence synthesis
about Immuno-Oncology drugs

Member of the meta|Evidence galaxy

Pathology  

Latest studies

BCTOP-T-A01 arm A/B, 2024

breast cancer - triple negative

gemcitabine plus platin

NCI 10013, 2022

breast cancer - triple negative

atezolizumab plus carboplatin plus paclitaxel

TBCRC, 2024

breast cancer - triple negative

carboplatin

SHR1210-III-322, 2024

breast cancer - triple negative

camrelizumab plus SOC

Treatments

457
treatments 		  408
studies 		  1388
references
This project is supported by H2020 Qualitop, an EU-funded project, Hospices Civils de Lyon and CNRS UMR5558 LBBE.
     

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons